Literature DB >> 24045188

Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters.

Tao Zhang1, Joshua E Lubek2, Andrew Salama3, Donita Dyalram2, Xinggang Liu4, Robert A Ord5.   

Abstract

PURPOSE: The objective of the present study was to summarize the treatment and outcomes of cT1N0M0 tongue cancer for which the management is less defined.
MATERIALS AND METHODS: A total of 65 consecutive cases of cT1 tongue cancer were retrospectively reviewed. The Fisher exact, χ(2), and Wilcoxon tests were used to statistically analyze the data.
RESULTS: The tumor depth had a significant relation to the presence of neck metastasis (P < .05). A 3-mm cutoff point provided better predictive value, with a sensitivity of 92.9% and specificity of 43.1%. The biopsy depth combined with palpation was accurate in determining the tumor depth preoperatively in 87.7%. On multivariate analysis, only the tumor site (ventral tongue) and the presence of erythroleukoplakia had any significant relation to disease-free survival (P = .010).
CONCLUSIONS: Elective neck dissection should be considered for patients with cT1N0 oral tongue squamous carcinoma with a biopsy depth of 3 mm or greater. The biopsy depth, combined with the clinical examination findings, is a useful method to help determine the tumor depth preoperatively.
Copyright © 2014 American Association of Oral and Maxillofacial Surgeons. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24045188     DOI: 10.1016/j.joms.2013.05.028

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  12 in total

1.  miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.

Authors:  Duo Li; Ke Liu; Zhiyong Li; Jian Wang; Xiaofeng Wang
Journal:  Cell Adh Migr       Date:  2017-11-13       Impact factor: 3.405

2.  Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis.

Authors:  Samer Ahmed Ibrahim; Ahmed Nabil Abdelhamid Ahmed; Hisham Abdelaty Elsersy; Islam Mohammed Hussein Darahem
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-25       Impact factor: 2.503

3.  Elective Neck Dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue.

Authors:  D Mirea; R Grigore; D Safta; L Mirea; Cr Popescu; B Popescu; Svg Berteşteanu
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

Review 4.  Epidemiologic trends in head and neck cancer and aids in diagnosis.

Authors:  Nadarajah Vigneswaran; Michelle D Williams
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2014-05       Impact factor: 2.802

5.  Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India.

Authors:  Nootan Kumar Shukla; S V Suryanarayana Deo; Pankaj Kumar Garg; N M L Manjunath; Suman Bhaskar; V Sreenivas
Journal:  Indian J Surg Oncol       Date:  2017-05-11

6.  Overexpression of transforming growth factor type III receptor restores TGF-β1 sensitivity in human tongue squamous cell carcinoma cells.

Authors:  Duo Li; Dongyang Xu; Zhiyong Lu; Xingli Dong; Xiaofeng Wang
Journal:  Biosci Rep       Date:  2015-07-23       Impact factor: 3.840

7.  Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.

Authors:  Xing Yang; Jinyu Zhu; Yongming Dai; Zhen Tian; Gongxin Yang; Huimin Shi; Yingwei Wu; Xiaofeng Tao
Journal:  BMC Med Imaging       Date:  2019-03-12       Impact factor: 1.930

8.  Oral squamous cell carcinoma of tongue: Histological risk assessment. A pilot study.

Authors:  B-C Migueláñez-Medrán; J-J Pozo-Kreilinger; J-L Cebrián-Carretero; M-A Martínez-García; A-F López-Sánchez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2019-09-01

9.  Incidence and outcome for patients with occult lymph node involvement in T1 and T2 oral squamous cell carcinoma: a prospective study.

Authors:  Thomas Mücke; David A Mitchell; Stefan Wagenpfeil; Lucas M Ritschl; Klaus-Dietrich Wolff; Anastasios Kanatas
Journal:  BMC Cancer       Date:  2014-05-20       Impact factor: 4.430

10.  SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression.

Authors:  Xiaoming Liu; Baorong Zhang; Yue Jia; Ming Fu
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.